• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构建全基因组蛋白质标记细胞和小鼠文库。

Construction of genome-wide protein tagging cell and mouse libraries.

机构信息

Genome Tagging Project Center, Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai 200031, China.

出版信息

Yi Chuan. 2021 Jul 20;43(7):704-714. doi: 10.16288/j.yczz.21-163.

DOI:10.16288/j.yczz.21-163
PMID:34284985
Abstract

Mice are the most widely used model organism for the study of gene functions and disease mechanisms through the generation of gene-modified mice. Since the 1980s, different genetic manipulation technologies have been developed to reveal gene functions in vivo, including homologous recombination strategies mediated by embryonic stem cells, transgenic strategies mediated by gametes, and the latest genetic modification strategies based on CRISPR/Cas9 technology. Semi-cloning technology mediated by "artificial spermatids" (androgenetic haploid embryonic stem cells, also termed sperm-like stem cells) is developed by Chinese scientists in 2012. In combination with CRISPR/Cas9, semi-cloning technology enables one-step generation of gene-modified mice through injection of "artificial spermatids" with specific gene modifications into oocytes. It has the characteristics of short construction cycle, high efficiency, low cost, and high application compatibility. In 2017, the Center for Excellence in Molecular Cell Science (CEMCS) of CAS has launched the genome tagging project (GTP) based on "artificial spermatid"-mediated semi-cloning technology. The ambitious goal of GTP is to tag every protein in mice and construct a unique mouse library that maintains the genome-wide protein-tagging mouse models. Subsequently, the GTP center was established at CEMCS to pursue the project. GTP center developed strategies to generate protein-tagging cells and mice. Briefly, a tag sequence is precisely inserted in a specific protein- coding gene endogenously in cultured "artificial spermatids"in vitro to build a cell library, in which, each cell line carrying a specific protein tag. The tagged cells could be further used as a sperm replacement to produce tagged mice in one step upon injection into oocytes. The tagged mouse library enables global analysis of protein expression, localization, and complexes using standard tag-based assays in vivo. By April 2021, the GTP center has generated 1532 tagged cell lines, 277 of which have been successfully used to produce tagged mice through oocyte injection. A total of 242 tagged mouse strains have been distributed to 66 research teams in 32 research institutions of 15 districts in 3 countries. The database of tagging product resources has been established and released regularly on the GTP website for scientists to inquire and order. Later, more information about GTP products, such as mouse breeding, protein tissue expression map, published literature, etc., will also be successively published on the GTP website. The GTP center will provide a standardized platform for protein function research, which may dramatically promote the development of life science and clinical transformation.

摘要

小鼠是研究基因功能和疾病机制的最广泛使用的模式生物,通过生成基因修饰小鼠来实现。自 20 世纪 80 年代以来,已经开发出不同的遗传操作技术来在体内揭示基因功能,包括由胚胎干细胞介导的同源重组策略、由配子介导的转基因策略,以及基于 CRISPR/Cas9 技术的最新遗传修饰策略。“人工精子”(雄原核胚胎干细胞,也称为精子样干细胞)介导的半克隆技术是中国科学家于 2012 年开发的。与 CRISPR/Cas9 结合使用,半克隆技术可通过将具有特定基因修饰的“人工精子”注射到卵母细胞中,一步生成基因修饰小鼠。它具有构建周期短、效率高、成本低、应用兼容性强的特点。2017 年,中国科学院分子细胞科学卓越创新中心(CEMCS)启动了基于“人工精子”介导的半克隆技术的基因组标记项目(GTP)。GTP 的雄心勃勃的目标是标记小鼠中的每一种蛋白质,并构建一个独特的保持全基因组蛋白标记小鼠模型的文库。随后,CEMCS 成立了 GTP 中心来推进该项目。GTP 中心开发了生成蛋白标记细胞和小鼠的策略。简而言之,通过在体外培养的“人工精子”中精确地将一个标记序列插入到一个特定的蛋白质编码基因的内源中,构建一个细胞文库,其中每个细胞系携带一个特定的蛋白标记。标记后的细胞可以通过注射到卵母细胞中一步转化为标记的小鼠。标记的小鼠文库使全球分析蛋白质表达、定位和复合物成为可能,在体内使用标准的标记基检测方法。截至 2021 年 4 月,GTP 中心已生成 1532 个标记细胞系,其中 277 个已成功通过卵母细胞注射用于产生标记的小鼠。总共 242 个标记的小鼠品系已分发给 3 个国家 15 个区的 32 个研究机构的 66 个研究团队。标记产物资源数据库已建立,并定期在 GTP 网站上发布,供科学家查询和订购。之后,更多关于 GTP 产品的信息,如小鼠繁殖、蛋白质组织表达图谱、已发表文献等,也将陆续在 GTP 网站上发布。GTP 中心将为蛋白质功能研究提供一个标准化的平台,这可能会极大地促进生命科学和临床转化的发展。

相似文献

1
Construction of genome-wide protein tagging cell and mouse libraries.构建全基因组蛋白质标记细胞和小鼠文库。
Yi Chuan. 2021 Jul 20;43(7):704-714. doi: 10.16288/j.yczz.21-163.
2
'Artificial spermatid'-mediated genome editing†.“人工精子细胞”-介导的基因组编辑†。
Biol Reprod. 2019 Sep 1;101(3):538-548. doi: 10.1093/biolre/ioz087.
3
Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences.CRISPR/Cas9 靶向敲除 POU5F1 后对小鼠和人类植入前胚胎发育的比较分析揭示了种间差异。
Hum Reprod. 2021 Apr 20;36(5):1242-1252. doi: 10.1093/humrep/deab027.
4
Analysis of microsatellite instability in CRISPR/Cas9 editing mice.CRISPR/Cas9编辑小鼠中微卫星不稳定性的分析
Mutat Res. 2017 Mar;797-799:1-6. doi: 10.1016/j.mrfmmm.2017.02.003. Epub 2017 Feb 28.
5
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
6
Off- and on-target effects of genome editing in mouse embryos.小鼠胚胎中基因编辑的脱靶效应和靶向效应。
J Reprod Dev. 2019 Feb 8;65(1):1-5. doi: 10.1262/jrd.2018-128. Epub 2018 Dec 6.
7
Application of genetic modification technologies in molecular design breeding of sheep.遗传修饰技术在绵羊分子设计育种中的应用。
Yi Chuan. 2021 Jun 20;43(6):580-600. doi: 10.16288/j.yczz.21-087.
8
Highly Efficient One-Step Tagging of Endogenous Genes in Primary Cells Using CRISPR-Cas Ribonucleoproteins.使用CRISPR-Cas核糖核蛋白在原代细胞中高效一步标记内源性基因
CRISPR J. 2022 Dec;5(6):843-853. doi: 10.1089/crispr.2022.0046. Epub 2022 Nov 24.
9
CRISPR-Cas9 Genome Editing and Rapid Selection of Cell Pools.CRISPR-Cas9 基因组编辑和细胞池的快速选择。
Curr Protoc. 2022 Dec;2(12):e624. doi: 10.1002/cpz1.624.
10
[CRISPR/Cas9 technology in disease research and therapy: a review].[CRISPR/Cas9技术在疾病研究与治疗中的应用综述]
Sheng Wu Gong Cheng Xue Bao. 2021 Apr 25;37(4):1205-1228. doi: 10.13345/j.cjb.200401.